Beta-Alanine → 3-{[7-(3-Benzyl-ureido)-4-hydroxy-isoquinoline-3-carbonyl]-amino}-propionic acid
반응식
C(O[C:4]([C:6]1[N:7]=[CH:8][C:9]2[C:14]([C:15]=1[OH:16])=[CH:13][CH:12]=[C:11]([NH:17][C:18]([NH:20][CH2:21][C:22]1[CH:27]=[CH:26][CH:25]=[CH:24][CH:23]=1)=[O:19])[CH:10]=2)=[O:5])C.[NH2:28][CH2:29][CH2:30][C:31]([OH:33])=[O:32]>>[CH2:21]([NH:20][C:18](=[O:19])[NH:17][C:11]1[CH:10]=[C:9]2[C:14]([C:15]([OH:16])=[C:6]([C:4]([NH:28][CH2:29][CH2:30][C:31]([OH:33])=[O:32])=[O:5])[N:7]=[CH:8]2)=[CH:13][CH:12]=1)[C:22]1[CH:27]=[CH:26][CH:25]=[CH:24][CH:23]=1참가 물질
3
실험 절차
3-{[7-(3-Benzyl-ureido)-4-hydroxy-isoquinoline-3-carbonyl]-amino}-propionic acid was prepared from 7-(3-Benzyl-ureido)-4-hydroxy-isoquinoline-3-carboxylic acid ethyl ester under conditions analogous to Example 116(b) using beta-alanine. MS ESI(−) m/e: 407.0882 (M−1).
출처 및 근거
- ORD 기록
- ord-8b83da03687a4ebbb79926407ff08cc1
- 출처 데이터셋
- uspto-grants-2016_08
- 특허 번호
- US09409892B2
반응 노트
불러오는 중…